(Q80527609)
Statements
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study (English)
G Rosati
D Bilancia
D Germano
A Dinota
R Romano
G Reggiardo